{"count":220363,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1309","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1307","results":[{"created":"2021-06-05T17:13:26.224683+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3808","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: UBE3B were set to ","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:13:00.956008+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3807","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: UBE3B was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:12:27.660617+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3806","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: UBE3B: Rating: GREEN; Mode of pathogenicity: None; Publications: 23200864, 23200864, 34012380, 32949109; Phenotypes: Kaufman oculocerebrofacial syndrome, MIM# 244450, MONDO:0009485; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:11:46.535659+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: UBE3B as ready","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:11:46.525540+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ube3b has been classified as Green List (High Evidence).","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:11:44.182274+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: UBE3B were changed from  to Kaufman oculocerebrofacial syndrome, MIM# 244450; MONDO:0009485","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:11:14.497476+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: UBE3B were set to ","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:10:49.828386+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: UBE3B was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T17:10:26.447605+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: UBE3B: Rating: GREEN; Mode of pathogenicity: None; Publications: 23200864, 23200864, 34012380, 32949109; Phenotypes: Kaufman oculocerebrofacial syndrome, MIM# 244450, MONDO:0009485; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"UBE3B","entity_type":"gene"},{"created":"2021-06-05T15:04:33.123121+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: KANSL1.","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:04:18.706714+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KANSL1 as ready","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:04:18.691330+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kansl1 has been classified as Green List (High Evidence).","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:04:16.149198+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KANSL1 were changed from  to Koolen-De Vries syndrome, MIM# 610443; MONDO:0012496","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:03:46.845598+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: KANSL1 were set to ","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:03:24.510258+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.50","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KANSL1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:02:53.719946+10:00","panel_name":"Angelman Rett like syndromes","panel_id":41,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: KANSL1: Rating: GREEN; Mode of pathogenicity: None; Publications: 19447831, 22544367, 22544363; Phenotypes: Koolen-De Vries syndrome, MIM# 610443, MONDO:0012496; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:01:45.754504+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KANSL1 as ready","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:01:45.740115+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kansl1 has been classified as Green List (High Evidence).","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:01:42.182583+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: KANSL1.","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:01:34.663500+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KANSL1 were changed from Koolen-De Vries syndrome, MIM# 610443 to Koolen-De Vries syndrome, MIM# 610443; MONDO:0012496","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:00:53.888930+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KANSL1 were changed from  to Koolen-De Vries syndrome, MIM# 610443","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T15:00:30.513127+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.37","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: KANSL1 were set to ","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T14:59:53.417004+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KANSL1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T14:59:24.062771+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: KANSL1: Rating: GREEN; Mode of pathogenicity: None; Publications: 19447831, 22544367, 22544363; Phenotypes: Koolen-De Vries syndrome, MIM# 610443; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KANSL1","entity_type":"gene"},{"created":"2021-06-05T14:51:14.423348+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HUWE1 as ready","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:51:14.412648+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: huwe1 has been classified as Green List (High Evidence).","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:51:11.757102+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HUWE1 were changed from  to Mental retardation, X-linked syndromic, Turner type, MIM# 309590; MONDO:0010407","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:50:48.880746+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HUWE1 were set to ","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:50:18.201888+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HUWE1 was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:49:53.109592+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HUWE1 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:49:29.955757+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HUWE1: Rating: GREEN; Mode of pathogenicity: None; Publications: 18252223, 29180823; Phenotypes: Mental retardation, X-linked syndromic, Turner type, MIM# 309590, MONDO:0010407; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"HUWE1","entity_type":"gene"},{"created":"2021-06-05T14:46:21.964479+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HSPG2 as ready","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:46:21.955149+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hspg2 has been classified as Green List (High Evidence).","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:46:19.528228+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HSPG2 were changed from  to Schwartz-Jampel syndrome, type 1, MIM# 255800; MONDO:0009717","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:45:54.722492+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.273","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HSPG2 were set to ","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:45:28.028580+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.272","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HSPG2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:45:04.400991+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.271","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HSPG2: Rating: GREEN; Mode of pathogenicity: None; Publications: 11101850, 16927315; Phenotypes: Schwartz-Jampel syndrome, type 1, MIM# 255800, MONDO:0009717; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:43:51.361770+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7851","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HSPG2 were set to 16927315","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:43:26.334224+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7850","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HSPG2: Rating: GREEN; Mode of pathogenicity: None; Publications: 11101850, 16927315, 11279527; Phenotypes: Schwartz-Jampel syndrome, type 1, MIM# 255800, MONDO:0009717, Dyssegmental dysplasia, Silverman-Handmaker type, MIM# 224410, MONDO:0009140; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:39:53.015206+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HSPG2 as ready","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:39:52.991855+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hspg2 has been classified as Green List (High Evidence).","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:39:49.163699+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HSPG2 were changed from  to Schwartz-Jampel syndrome, type 1, MIM# 255800; MONDO:0009717","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:39:21.542262+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HSPG2 were set to ","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:38:54.517371+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.29","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HSPG2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T14:38:29.412522+10:00","panel_name":"Blepharophimosis","panel_id":55,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HSPG2: Rating: GREEN; Mode of pathogenicity: None; Publications: 11101850, 16927315; Phenotypes: Schwartz-Jampel syndrome, type 1, MIM# 255800, MONDO:0009717; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPG2","entity_type":"gene"},{"created":"2021-06-05T12:40:35.980336+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7850","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HLA-DRB1 as ready","entity_name":"HLA-DRB1","entity_type":"gene"},{"created":"2021-06-05T12:40:35.969847+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7850","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-drb1 has been classified as Red List (Low Evidence).","entity_name":"HLA-DRB1","entity_type":"gene"},{"created":"2021-06-05T12:40:27.416259+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7850","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HLA-DRB1 as Red List (low evidence)","entity_name":"HLA-DRB1","entity_type":"gene"},{"created":"2021-06-05T12:40:27.405374+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7850","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-drb1 has been classified as Red List (Low Evidence).","entity_name":"HLA-DRB1","entity_type":"gene"},{"created":"2021-06-05T12:40:09.590702+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7849","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HLA-DRB1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"HLA-DRB1","entity_type":"gene"},{"created":"2021-06-05T12:39:39.547513+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7849","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HLA-DRA as ready","entity_name":"HLA-DRA","entity_type":"gene"},{"created":"2021-06-05T12:39:39.538166+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7849","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-dra has been classified as Red List (Low Evidence).","entity_name":"HLA-DRA","entity_type":"gene"},{"created":"2021-06-05T12:39:31.667233+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7849","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HLA-DRA as Red List (low evidence)","entity_name":"HLA-DRA","entity_type":"gene"},{"created":"2021-06-05T12:39:31.655528+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7849","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-dra has been classified as Red List (Low Evidence).","entity_name":"HLA-DRA","entity_type":"gene"},{"created":"2021-06-05T12:39:16.497176+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7848","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HLA-DRA: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"HLA-DRA","entity_type":"gene"},{"created":"2021-06-05T12:38:44.197309+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7848","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HLA-C as ready","entity_name":"HLA-C","entity_type":"gene"},{"created":"2021-06-05T12:38:44.183050+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7848","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-c has been classified as Red List (Low Evidence).","entity_name":"HLA-C","entity_type":"gene"},{"created":"2021-06-05T11:29:05.106888+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7848","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HLA-C as Red List (low evidence)","entity_name":"HLA-C","entity_type":"gene"},{"created":"2021-06-05T11:29:05.097083+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7848","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-c has been classified as Red List (Low Evidence).","entity_name":"HLA-C","entity_type":"gene"},{"created":"2021-06-05T11:28:44.467501+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7847","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HLA-C: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"HLA-C","entity_type":"gene"},{"created":"2021-06-05T11:28:18.853294+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7847","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HLA-B as ready","entity_name":"HLA-B","entity_type":"gene"},{"created":"2021-06-05T11:28:18.843178+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7847","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-b has been classified as Red List (Low Evidence).","entity_name":"HLA-B","entity_type":"gene"},{"created":"2021-06-05T11:28:09.868500+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7847","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HLA-B as Red List (low evidence)","entity_name":"HLA-B","entity_type":"gene"},{"created":"2021-06-05T11:28:09.858174+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7847","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-b has been classified as Red List (Low Evidence).","entity_name":"HLA-B","entity_type":"gene"},{"created":"2021-06-05T11:27:52.260352+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7846","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HLA-B: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"HLA-B","entity_type":"gene"},{"created":"2021-06-05T11:27:21.911053+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7846","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HLA-A as ready","entity_name":"HLA-A","entity_type":"gene"},{"created":"2021-06-05T11:27:21.901321+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7846","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-a has been classified as Red List (Low Evidence).","entity_name":"HLA-A","entity_type":"gene"},{"created":"2021-06-05T11:27:13.055974+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7846","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HLA-A as Red List (low evidence)","entity_name":"HLA-A","entity_type":"gene"},{"created":"2021-06-05T11:27:13.045748+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7846","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hla-a has been classified as Red List (Low Evidence).","entity_name":"HLA-A","entity_type":"gene"},{"created":"2021-06-05T11:26:56.609957+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7845","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HLA-A: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"HLA-A","entity_type":"gene"},{"created":"2021-06-05T11:26:17.792927+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7845","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TAF6 as ready","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:26:17.782986+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7845","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: taf6 has been classified as Green List (High Evidence).","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:26:05.357930+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7845","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TAF6 were changed from  to Alazami-Yuan syndrome, MIM# 617126","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:25:39.287665+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7844","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TAF6 were set to ","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:24:16.142347+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7843","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TAF6 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:23:54.922970+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7842","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TAF6: Rating: GREEN; Mode of pathogenicity: None; Publications: 25558065, 25574841, 32030742; Phenotypes: Alazami-Yuan syndrome, MIM# 617126; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:22:04.036763+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3806","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TAF6 as ready","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:22:04.026626+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3806","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: taf6 has been classified as Green List (High Evidence).","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:21:59.177562+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3806","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TAF6 were changed from Alazami-Yuan syndrome, MIM# 617126 to Alazami-Yuan syndrome, MIM# 617126","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:21:44.141069+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3806","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TAF6 were changed from  to Alazami-Yuan syndrome, MIM# 617126","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:21:13.833359+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3805","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TAF6 were set to ","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:20:52.136588+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3804","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TAF6 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:19:00.873334+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.3803","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TAF6: Rating: GREEN; Mode of pathogenicity: None; Publications: 25558065, 25574841, 32030742; Phenotypes: Alazami-Yuan syndrome, MIM# 617126; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TAF6","entity_type":"gene"},{"created":"2021-06-05T11:00:03.303942+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7842","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ANGPT2 were changed from Primary lymphoedema to Lymphatic malformation-10, MIM#619369; Primary lymphoedema","entity_name":"ANGPT2","entity_type":"gene"},{"created":"2021-06-05T10:59:43.642408+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7841","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: ANGPT2: Changed phenotypes: Lymphatic malformation-10, MIM#619369, Primary lymphoedema","entity_name":"ANGPT2","entity_type":"gene"},{"created":"2021-06-04T20:07:28.084646+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"panel","text":"promoted panel to version 1.0","entity_name":null,"entity_type":null},{"created":"2021-06-04T20:07:08.995595+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.62","user_name":"Zornitza Stark","item_type":"panel","text":"Panel types changed to Victorian Clinical Genetics Services; Rare Disease","entity_name":null,"entity_type":null},{"created":"2021-06-04T20:06:26.046503+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7841","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC24A5 as ready","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:06:26.035332+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7841","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc24a5 has been classified as Green List (High Evidence).","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:06:13.999233+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7841","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC24A5 were changed from  to Albinism, oculocutaneous, type VI, MIM# 113750","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:05:55.875590+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7840","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLC24A5 were set to ","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:05:41.336930+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.61","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC24A5 as ready","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:05:41.326713+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.61","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc24a5 has been classified as Green List (High Evidence).","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:05:36.767096+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7839","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SLC24A5 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:05:19.943842+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.61","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC24A5 were changed from  to Albinism, oculocutaneous, type VI, MIM# 113750","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:05:17.523402+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7838","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SLC24A5: Rating: GREEN; Mode of pathogenicity: None; Publications: 23364476, 23985994, 26491832; Phenotypes: Albinism, oculocutaneous, type VI, MIM# 113750; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:04:33.302659+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLC24A5 were set to ","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:04:09.953574+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.59","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SLC24A5 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:03:26.264817+10:00","panel_name":"Ocular and Oculocutaneous Albinism","panel_id":37,"panel_version":"0.58","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SLC24A5: Rating: GREEN; Mode of pathogenicity: None; Publications: 23364476, 23985994, 26491832; Phenotypes: Albinism, oculocutaneous, type VI, MIM# 113750; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC24A5","entity_type":"gene"},{"created":"2021-06-04T20:01:05.732321+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7838","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC45A2 as ready","entity_name":"SLC45A2","entity_type":"gene"}]}